-
Uncategorized3 weeks ago
AbbVie’s new immunology standard-bearer Skyrizi kneels to UCB’s Bimzelx in psoriatic arthritis
UCB’s Bimzelx elicited significantly stronger joint relief at 16 weeks than AbbVie’s Skyrizi in a Phase 3 head-to-head study of psoriatic arthritis.
-
Uncategorized3 weeks agoAfter Rubio’s critique, WHO defends work on Ebola response
World Health Organization officials on Wednesday mounted a defense of their response to the new and worrisome Ebola outbreak centered in the Democratic Republic of the...
-
Uncategorized3 weeks ago
FDA’s absent leaders, the millions pharma CEOs make, and pancreatic cancer’s momentum
Fallout from the resignation of FDA Commissioner Marty Makary continues as several other senior regulators are removed from their posts; pharma’s top paid CEOs make up...
-
Uncategorized3 weeks ago
Parabilis reveals IPO plans the day after Regeneron deal as listings heat up
Parabilis Medicines, the decade-old and well-funded “undruggable” biotech out of Greg Verdine’s Harvard lab, seeks to become the 12th drug developer to conduct an initial public...
-
Uncategorized3 weeks agoSTAT+: Senate Democrats propose adding long-term care benefit to Medicare
WASHINGTON — A group of Senate Democrats is proposing that Medicare cover in-home care, which would create the first new benefit in the program since the...
-
Uncategorized3 weeks agoNIH behind in filling top roles, with 15 of 27 institutes led by acting directors
Across the Department of Health and Human Services, top leadership positions are being filled with acting directors. There is no permanent director at the Centers for...
-
Uncategorized3 weeks ago
Daiichi emerges from bruising 2 years with vision for cracking cancer’s big leagues
Clinical trial setbacks have limited the near-term opportunities for some of Daiichi Sankyo’s ADCs but the drug developer is betting near-term readouts will catapult it into...
-
Uncategorized3 weeks ago
J&J’s Duato makes 358 times his median employee; Vertex CEO makes just 80 times
BioSpace analyzed the pay ratio across 10 major pharmaceutical companies to determine which CEOs were paid the most relative to typical employees. J&J, Eli Lilly and...
-
Uncategorized3 weeks ago
Regeneron, Parabilis Ink Up-to-$2.3B Antibody-Peptide Conjugate Collaboration
Regeneron, Parabilis Ink Up-to-$2.3B Antibody-Peptide Conjugate Collaboration
-
Uncategorized3 weeks agoSTAT+: 23andMe offers to connect users’ DNA data with medical records
23andMe plans to give its customers the capacity to import their medical records, allowing what it calls “a 360-degree view of their personal health.” The offering...
FDA imposes import alert on Indian plant after inspectors flag GMP failings
